38 Followers on Owler

Spero Therapeutics

is a Massachusetts-based biopharmaceutical company that develops novel therapeutics for the treatment of bacterial and urinary tract infections... Read more
OverviewCompetitorsFundingNews & Insights

Spero Therapeutics

is a Massachusetts-based biopharmaceutical company that develops novel therapeutics for the treatment of bacterial and urinary tract infections... Read more
Spero Therapeutics President & CEO: Esther Rajavelu

President & CEO

Esther Rajavelu

CEO Approval Rating

82/100

2013

PublicNASDAQSPRO

Pharmaceuticals & Biotechnology
Pharmaceuticals
2836 NAICS listing

Annual Revenue
$61.2M
Employees
150
Funding
$463.8M

News

Leadership Change
May 02, 2025
GlobeNewswire
Esther Rajavelu is now President & CEO at Spero Therapeutics

Spero Therapeutics Competitors

1Melinta
2Tetraphase
3Cipla
4UTILITY Therapeutics
5Adenium Biotech
6Achaogen
7VIBATIV
8Pear
Unlock 5 + competitors

Trending Companies